{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "52028481",
    "validDate": "2028-05-16 00:00:00.000",
    "issueDate": "2023-05-16 00:00:00.000",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202848102",
    "prodNameC": "癌沛特\"山德士\"25毫克\/毫升注射劑",
    "prodNameE": "Pemetrexed Sandoz 25mg\/mL Concentrate for solution for Infusion",
    "indicationsName": [
        "1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與pembrolizumab及含鉑化學療法併用，做為轉移性，不具有EGFR或ALK腫瘤基因異常之非鱗狀非小細胞肺癌的第一線治療藥物。5.與cisplatin併用於治療惡性肋膜間質細胞瘤。"
    ],
    "does": "2270",
    "packageUnit": [
        {
            "packageSpec": "100毫克\/4毫升、500毫克\/20毫升",
            "packageUnit": "L2"
        },
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "B",
    "ingredientsDesc": [
        "Pemetrexed disodium 2.5 hydrate"
    ],
    "restraintItemsCode": [
        "02",
        "24"
    ],
    "applicantName": "台灣山德士藥業股份有限公司",
    "applicantAddr": "臺北市中山區民生東路3段2號8樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "FAREVA Unterach GmbH",
            "factoryAddr": "MONDSEESTRASSE 11, 4866 UNTERACH AM ATTERSEE, AUSTRIA",
            "factoryCompanyAddr": "",
            "countryCode": "AT",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FAT0067000",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1004002420",
            "ingredientsDesc": "Pemetrexed disodium 2.5 hydrate",
            "concentDesc": "Pemetrexed....25mg (Pemetrexed Disodium 2.5 hydrate....30.2mg)",
            "concent": "25.000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [
        {
            "applicantName": "台灣諾華股份有限公司",
            "certNo": "DHA05202848113",
            "approveDocNo": "1130706504",
            "authDate": "2024-03-11",
            "validDate": "2027-02-02"
        }
    ],
    "iomDtoList": [],
    "changeDtoList": [
        {
            "licChgDocId": "2F41802B-FD1A-4DF6-9605-3B494357AE27",
            "approvedDocNo": "1139002380",
            "approvedDate": "2024-03-06",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "63192DA7-7B45-453A-814F-18970142851D",
            "approvedDocNo": "1120720457",
            "approvedDate": "2024-02-21",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "25B91066-C819-470D-A072-78F8461700F2",
            "approvedDocNo": "1120718570",
            "approvedDate": "2024-01-03",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        }
    ],
    "atcList": [],
    "licBaseId": "B35CDF77-FE37-457B-83BC-121E30B54198"
}